Oliver’s Law: Campaign Calls for Changes to Medical Cannabis Prescribing in Psychiatric Conditions
Psychiatric cannabis prescribing guidelines are urgently needed as patients increasingly seek medical cannabis for psychiatric conditions despite limited clinical trial data. Oliver's Law campaign highlights this evidence gap and calls for regulatory…
Germany’s Cannabis Reform Shows No Signs of Harm its Critics Predicted, Government Data Reveals
German cannabis legalization remains controversial despite early data showing no major harms. The 2024 reform has not produced the negative outcomes critics predicted. This suggests regulated cannabis access can coexist with public health safeguards.
Canadian Cannabis Companies Eye US Medicare CBD Pilot Project – StratCann
Canadian cannabis companies are positioning themselves to participate in the Medicare hemp pilot program, reflecting growing interest in CBD reimbursement pathways. This pilot could significantly impact how cannabis-derived therapeutics are integrated…
Cannabis Compounds CBD and CBG Fatty Liver Benefits in 2026
Cannabis compounds CBD and CBG fatty liver benefits are gaining attention for their potential to reduce hepatic steatosis. These cannabinoids show promise in improving liver health and metabolic markers. Clinicians should consider emerging evidence when…
cbdMD Launches Clinical Healthcare Channel to Support Federal Hemp CBD Pathway
cbdMD has launched a clinical healthcare channel hemp CBD to support the first federal pathway for hemp-derived CBD products. This initiative is backed by human clinical evidence from IRB-approved trials. It represents a significant step toward…
Howard Kessler Praises Policy Advances in CBD Access
CBD access policy developments are reshaping patient care and treatment planning. Clinicians must stay informed to provide accurate patient counseling. Understanding regulatory changes is essential for maintaining therapeutic relationships.
Medical Cannabis and Palliative Care: What This End-of-Life Study Actually Shows
This study examines medical cannabis and palliative care utilization among terminally diagnosed patients. It highlights patterns of cannabis use alongside or instead of nonhospice palliative care. The findings offer cautious insights but do not prove…
Hello from East Africa
Your endocannabinoid system doesn’t care about your zip code, but your local cannabinoid chemistry might. Turns out therapeutic potential is truly universal, even if regulatory frameworks aren’t. Via r/trees Further Reading Evidence…
Catching a whiff of weed in public got me like:
My olfactory system just conducted an impromptu cannabinoid identification test, and apparently I passed with flying colors. Via r/trees Further Reading Cannabis Policy WirePolicy Watch: 20 Regulatory Updates — March 20, 2026 Evidence…
‘I Hate This.’ Texas Cracks Down on THC, Maddening Us All.
When your state’s regulatory framework moves slower than a patient’s endocannabinoid system reaches homeostasis, you start questioning the evidence base of prohibition itself. Via r/trees Further Reading Research DigestResearch Digest: 5…
